Identification | Back Directory | [Name]
oxeglitazar | [CAS]
280585-34-4 | [Synonyms]
LM 4156 LM-4156 EMD336340 EMD-336340 EMD 336340 oxeglitazar 2,4-Pentadienoic acid, 5-(2,3-dihydro-7-methoxy-3,3-dimethyl-1-benzoxepin-5-yl)-3-methyl-, (2E,4E)- | [Molecular Formula]
C19H22O4 | [MDL Number]
MFCD10565967 | [MOL File]
280585-34-4.mol | [Molecular Weight]
314.38 |
Hazard Information | Back Directory | [Uses]
Oxeglitazar is an orally active compound that can be used for the research of type II diabetes[1]. | [References]
[1] antisolvent precipitation. Majerik V, et, al. Bioavailability enhancement of an active substance by supercritical. The Journal of Supercritical Fluids. Volume 40, Issue 1, February 2007, Pages 101-110 |
|
|